Bondholder Kenneth Dart, after staying quiet, says he wants full payment—just like Paul Singer
Does SodaStream's turn toward branding itself as a sparkling water vendor—and its dismal financial performance—suggest that it's seeking a different future?
A federal judge in New York refuses to exterminate an asbestos union's inflatable rat, saying "Scabby the Rat" is covered by the First Amendment
In October, more than two customers joined T-Mobile from a competitor for every customer that left it
Dominique Strauss-Kahn acquired a 20 percent stake in a Luxembourg finance firm last year, but quit his chairmanship on Oct. 20. His ex-partner Thierry Leyne died on Oct. 23
Ministry of Supply’s Aviator jacket combines the structure of a tailored garment with the functionality of a windbreaker
Marvel isn't keeping quiet about its movie plans now that DC has publicized its long slate of superhero vehicles
U.S. consumers are more likely to believe marketing materials that include charts and other scientific-looking things
This year's must-have Silicon Valley office accessory: a $199 bear costume
Founders: Cam Garner, Elaine Phillips, Malcolm Hill, and Adam Simpson
VC Investment over the last four quarters: $22.5 million
Founded in 2008, this nine-employee drug company develops products for the treatment of allergic inflammation of the gastrointestinal tract. "We identified a market that we believe has a true unmet medical need—in this particular instance there is no product approved by the FDA for the treatment of eosinophilic esophagitis," says a Meritage spokesperson in an e-mail. In the midst of the recession, its founders say that it is particularly important to stay focused on execution.
Key to startup success: "If we are able to successfully develop safe and effective products to meet the unmet medical needs of patients and their caregivers, we believe that capital will continue to be available."